Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sanofi SA

55.44
+1.342.48%
Post-market: 55.440.00000.00%18:37 EDT
Volume:2.25M
Turnover:125.06M
Market Cap:135.72B
PE:20.34
High:55.73
Open:55.50
Low:55.26
Close:54.10
Loading ...

Sanofi (SNY): Among the Best Foreign Dividend Stocks to Invest In Now

Insider Monkey
·
05 Feb

Q4 2024 Regeneron Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
05 Feb

Regeneron Beats on Q4 Earnings, Initiates Quarterly Dividend

Zacks
·
05 Feb

MRK Gets Positive CHMP Nod for 21-Valent Pneumococcal Jab Capvaxive

Zacks
·
04 Feb

L'Oreal to Sell $3.1 Billion Stake in Sanofi Back to Pharma Group -- Update

Dow Jones
·
03 Feb

Sanofi to Buyback $3 Billion in Shares From L'Oreal

MT Newswires Live
·
03 Feb

Pharma Stock Roundup: SNY and RHHBY's Q4 Earnings & More

Zacks
·
31 Jan

Sanofi SA (SNY) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Investments ...

GuruFocus.com
·
31 Jan

Stock Track | Sanofi Stock Soars 5.06% Intraday on Strong Q4 Results, Upbeat 2025 Outlook, and Share Buyback Plan

Stock Track
·
31 Jan

European Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday Trading

MT Newswires Live
·
31 Jan

Sanofi SA reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
30 Jan

Sector Update: Health Care Stocks Rise Pre-Bell Thursday

MT Newswires Live
·
30 Jan

Sanofi Misses on Q4 Earnings & Sales, Expects Higher Profits in 2025

Zacks
·
30 Jan

Sanofi: Q4 Earnings Snapshot

Associated Press Finance
·
30 Jan

Sanofi Q4 Business Earnings Decline, Revenue Increases; 2025 Sales Growth Guidance Issued

MT Newswires Live
·
30 Jan

Sanofi forecasts stronger profit growth, announces €5 billion stock buyback

Investing.com
·
30 Jan

Sanofi 2025 Guidance: Sales To Grow Mid-To-High Single Digits (CER), Business EPS To Rise Low Double Digits (CER); Plans A €5B Share Buyback

Benzinga
·
30 Jan

Sanofi Q4 2024 Adj. EPS $0.70 Misses $0.74 Estimate, Sales $11.275B Beat $11.162B Estimate

Benzinga
·
30 Jan

Sanofi Meets Estimates for Fourth-Quarter Profit, Plans 5 Billion Euros in Buybacks

Reuters
·
30 Jan

Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

GlobeNewswire
·
30 Jan